Charles.co

Overview
News
Telehealth?
Product stageSegments
Seed
?
Asynchronous Store and Forward Service
?

Charles.co offers virtual consultations and treatment plans for conditions such as sexual health, hair loss, and insomnia. The platform also delivers medication to an individual’s home and provides remote monitoring during treatment periods. As of June 2022, the platform has treated over 50,000 men with chronic conditions and has over six million monthly users across Europe.

In June 2022, the company raised EUR 7 million (USD 7.32 million) in a seed funding round co-led by Kurma Partners and Speedinvest. The funds were set aside to expand its offering to include additional chronic conditions and expand its workforce.

HQ location:
25, Rue du Petit-Musc Paris FRA
Founded year:
2019
Employees:
11-50
IPO status:
Private
Total funding:
USD 7.3 mn
Last Funding:
USD 7.3 mn (Seed; Jun 2022)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.